Bictegravir-induced drug reaction with eosinophilia and systemic symptoms in a patient with acute human immunodeficiency virus
Abstract
Although drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with antiretrovirals, there are no published reports of bictegravir-induced DRESS. Bictegravir is recommended as first-line treatment for patients with human immunodeficiency virus (HIV). Recognition of DRESS, its skin manifestations, and potential complications is vital for appropriate care and management of acute HIV.
Full citation:
DiLorenzo MA, Medrano N, Chen JN, Bawany F, Tran DC, Taunk P, Meehan SA, Pomeranz MK, Mgbako O (2023). Bictegravir-induced drug reaction with eosinophilia and systemic symptoms in a patient with acute human immunodeficiency virus
Open Forum Infectious Diseases, 10 (3), ofad066. doi: 10.1093/ofid/ofad066. PMCID: PMC9985146.